Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Items 201–300 of 733
Perioperative Identification and Management of Hyperglycemia in Orthopaedic Surgery
Lamanna, D. L., McDonnell, M. E., Chen, A. F., & Gallagher, J. M. (2022) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.22.00149 · Cited by 25
“Umpierrez et al.(75) (2011) I Basal-bolus treatment with insulin glargine once daily plus insulin glulisine before meals improved glycemic control and reduced hospital complications compared with sliding-scale insulin in general surgery patients.”
BackgroundUpdate on the perioperative management of diabetes mellitus
Polderman, J. A. W., Hermanides, J., & Hulst, A. H. (2024) · BJA Education · doi:10.1016/j.bjae.2024.04.007 · Cited by 26
“44 As such, the American Diabetes Association (ADA) guideline recommends a basal-bolus regimen in the postoperative ward in favour of sliding-scale insulin only.”
Pasquel, F. J., Urrutia, M. A., Cardona, S., Zamudio-Coronado, K. W., Albury, B. S., Perez‐Guzman, M. C., Galindo, R. J., Chaudhuri, A., Iacobellis, G., Palacios, J. D., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14347 · Cited by 27
“During the hospital stay, patients were managed with a standard basal or basal-bolus regimen according to hospital protocol.(9,16) Participants 1352 PASQUEL ET AL.”
MethodSelf-citationEmad-Eldin, M., Balata, G. F., el-Shorbagy, E., Hamed, M. S., & Attia, M. S. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i5.828 · Cited by 31
Setji, T. L., Hopkins, T. J., Jimenez, M., Manning, E., Shaughnessy, M., Schroeder, R., Mendoza-Lattes, S. A., Spratt, S. E., Westover, J. E., & Aronson, S. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0066 · Cited by 25
Advances in the management of hyperglycaemia and diabetes mellitus during hospitalization
Idrees, T., Castro-Revoredo, I., Dhatariya, K., Hernandez, L., & Umpierrez, G. E. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01157-1 · Cited by 25
“Several studies have demonstrated that the basal–bolus approach is effective and safe for managing most people with T2DM in general surgery or medical settings 58–60 .”
Self-citationReal-Time Continuous Glucose Monitoring in the Hospital: A Real-World Experience
Bagsic, S. R. S., Fortmann, A. L., Belasco, R. F., BASTIAN, A., Lohnes, S., Ritko, A. L., Sandoval, H., CHICHMARENKO, M., Soriano, E. C., Talavera, L., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231165982 · Cited by 27
“5) 8 (5-15) Discharge disposition Home 388 (43.”
Aberer, F., Lichtenegger, K. M., Smajic, E., Donsa, K., Malle, O., Samonigg, J., Höll, B., Beck, P., Pieber, T. R., Plank, J., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13559 · Cited by 25
“9 mmol/L) during basal-bolus therapy using insulin glargine U100 in surgical patients.(17) In a previous study using GlucoTab-guided basal-bolus therapy in combination with insulin glargine U100 in 99 inpatients, only 1.”
MethodCreating a Perioperative Glycemic Control Program
Alexanian, S. M., McDonnell, M. E., & Akhtar, S. (2011) · Anesthesiology Research and Practice · doi:10.1155/2011/465974 · Cited by 27
“programs are utilized [13, 15, 16], as there are many factors”
BackgroundUse Of Incretin-Based Therapy in Hospitalized Patients with Hyperglycemia
Umpierrez, G. E., & Schwartz, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13471.ra · Cited by 22
Self-citationJ, S. M., Salam, H. S., Viveka, S., & Udupa, A. L. (2017) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.198348 · Cited by 23
Newsom, R., Patty, C. M., Camarena, E., Sawyer, R., McFarland, R., Gray, T. L., & Mabrey, M. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817747619 · Cited by 22
“Hyperglycemia affects up to 40% of hospitalized patients and is associated with poor outcomes, including increased mortality, morbidity and length of stay.(1-7) Hyperglycemia can be related to poorly controlled or unrecognized/undiagnosed diabetes or hyperglycemia of acute illness.”
BackgroundGómez, A. M., Madero, A. I., Henao, D. C., Rondón, M., Múñoz, Ó., Gómez, M. A. R., Rebolledo, M., Maira, G., Vargas, F. M. L., & Umpierrez, G. E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818823720 · Cited by 22
Self-citationManaging hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach
Mabrey, M., Barton, A. B., Corsino, L., Freeman, S. B., Davis, E. D., Bell, E. L., & Setji, T. L. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1022493 · Cited by 23
“Over the past two decades, the management of hyperglycemia and diabetes in the inpatient setting has been the focus of many studies and recommendations [1-10].”
BackgroundPerioperative Glycemic Management of Patients Undergoing Bariatric Surgery
Rometo, D. A., & Korytkowski, M. T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0718-6 · Cited by 24
Inpatient dysglycemia and clinical outcomes: Association or causation?
Umpierrez, G. E., & Kosiborod, M. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.008 · Cited by 22
“…5% and 28.6% in ICU trials (Arabi et al., 2008; Finfer et al., 2009; Griesdale et al., 2009; van den Berghe et al., 2001; Van den Berghe et al., 2006) and 5% and 32% in non-ICU patients treated with subcutaneous insulin (Umpierrez et al., 2007; Umpierrez et al., 2009; Umpierrez et al., 2011).”
BackgroundInfluentialSelf-citationGalindo, R. J., Davis, G. M., Fayfman, M., Reyes-Umpierrez, D., Alfa, D., Peng, L., Tamler, R., Pasquel, F. J., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep171804.or · Cited by 21
Self-citationKrutkyte, G., GOERG, A. M. C., Grob, C. A., Piazza, C. D., Rolfes, E., Gloor, B., Wenning, A. S., Beldi, G., Kollmar, O., Hovorka, R., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006549 · Cited by 22
“34 – 36 In this context, the bene fi ts of tight glucose control may depend on the use of concomitant nutrition therapy, as supported by a recent multicentre randomized controlled trial which did not demonstrate improved patient outcomes with tight glucose versus more liberal glucose control in the…”
Glucose control in non‐critically ill inpatients with diabetes: towards closed‐loop
Thabit, H., & Hovorka, R. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12228 · Cited by 24
“There is an understanding that better glycaemic control in the general ward, if achieved safely, is beneficial rather than detrimental [11,19].”
BackgroundTamler, R., Green, D. E., Skamagas, M., Breen, T. L., Lu, K., Looker, H. C., Babyatsky, M. W., & LeRoith, D. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00189.x · Cited by 22
Thabit, H., & Hovorka, R. (2018) · Diabetic Medicine · doi:10.1111/dme.13563 · Cited by 22
The Future is Now: Software-Guided Intensive Insulin Therapy in the Critically Ill
Rattan, R., & Nasraway, S. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700231 · Cited by 22
Liu, H., Zhang, W., Hu, Q., Liu, L., Xie, Z., Xu, Y., Jing, G., & Wang, Y. (2022) · International Wound Journal · doi:10.1111/iwj.13948 · Cited by 20
Kyi, M., Gorelik, A., Reid, J. E. A., Rowan, L. M., WRAIGHT, P. R., Colman, P. G., & Fourlanos, S. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.06.006 · Cited by 20
How should rheumatologists manage glucocorticoid-induced hyperglycemia?
Nakamura, H., Fujieda, Y., Nakamura, A., & Atsumi, T. (2020) · Modern Rheumatology · doi:10.1080/14397595.2020.1823060 · Cited by 20
Outcomes of “Real-World” Insulin Strategies in the Management of Hospital Hyperglycemia
Sadhu, A., Patham, B., Vadhariya, A., Chikermane, S. G., & Johnson, M. L. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab101 · Cited by 20
“003) [24]; however, BB resulted in more hypoglycemia than SS in both trials [23, 24].”
BackgroundMethodInfluentialPanayi, A. C., Knoedler, S. A., Alfertshofer, M. G., Matar, D. Y., Friedrich, S., Rühl, J., Haug, V., Gazyakan, E., Bigdeli, A. K., Kneser, U., et al. (2025) · Annals of Surgery · doi:10.1097/sla.0000000000006664 · Cited by 20
Basal-Bolus Insulin Protocols Enter the Computer Age
Wei, N., & Wexler, D. J. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0240-9 · Cited by 19
Vaidya, A., Hurwitz, S., Yialamas, M. A., Min, L., & Garg, R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0258 · Cited by 22
“5,6 Preprinted order sets or electronic reminders for basal bolus insulin have been shown to improve glycemic control and are recommended by the AACE/ADA.”
BackgroundDiabetes management before, during, and after bariatric and metabolic surgery
Kheniser, K. G., & Kashyap, S. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.06.006 · Cited by 20
Steroid-induced hyperglycaemia in hospitalised patients: does it matter?
Cheung, N. W. (2016) · Diabetologia · doi:10.1007/s00125-016-4116-z · Cited by 19
Evaluation of the timing and coordination of prandial insulin administration in the hospital
Alwan, D., Chipps, E., Yen, P.-Y., & Dungan, K. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.06.021 · Cited by 18
Hyperglycemia in the Perioperative Period
Shuford, R., & Miller-Ocuin, J. L. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1761153 · Cited by 19
Subcutaneous Insulin Dosing Calculators for Inpatient Glucose Control
Ullal, J., & Aloi, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1254-y · Cited by 18
Documento de consenso sobre el tratamiento al alta hospitalaria del paciente con hiperglucemia
Pérez, A., Gómez‐Huelgas, R., Guisasola, F. Á., Alegría, J. G., Bravo, J. J. M., & Torre, E. L. M. (2012) · Medicina Clínica · doi:10.1016/j.medcli.2012.02.019 · Cited by 19
Computerized Insulin Order Sets and Glycemic Control in Hospitalized Patients
Wong, B., Mamdani, M., & Yu, C. H. Y. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2016.09.034 · Cited by 18
Flory, J. H., Aleman, J. O., Furst, J., & Seley, J. J. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813520367 · Cited by 17
“Guidelines recommend use of insulin to prevent hyperglycemia in hospitalized patients,(1,2) and randomized trials have shown that regimens that include basal insulin are more effective than rapid-acting insulin alone.(3-5) These trials also show that basal insulin increases the rate of hypoglycemia, a fact that likely…”
BackgroundHelmle, K. E., Chacko, S., Chan, T., Drake, A., Edwards, A. L., Moore, G., Philp, L. C., Popeski, N., Roedler, R. L., Rogers, E., et al. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.12.010 · Cited by 18
Positionspapier: Operation und Diabetes mellitus (Update 2023)
Kietaibl, A.-T., Huber, J., Clodi, M., Abrahamian, H., Ludvik, B. H., & Fasching, P. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02121-z · Cited by 19
Huri, H. Z., Permalu, V., & Vethakkan, S. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106505 · Cited by 17
Dungan, K. M., Han, W., Miele, A., Zeidan, T., & Weiland, K. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600420 · Cited by 18
Perez, A., Carrasco-Sánchez, F. J., González, C., Seguí-Ripoll, J. M., Trescolí, C., Ena, J., Borrell, M., & Gomez Huelgas, R. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001518 · Cited by 16
Umpierrez, G. E., Castro-Revoredo, I., Moazzami, B., Nayberg, I., Zabala, Z. E., Galindo, R. J., Vellanki, P., Peng, L., & Klonoff, D. C. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.11.018 · Cited by 16
Self-citationHorton, W. B., Law, S., Darji, M., Conaway, M. R., Akbashev, M. Y., Kubiak, N. T., Kirby, J. L., & Thigpen, S. (2019) · Endocrine Practice · doi:10.4158/ep-2019-0299 · Cited by 16
“Fifth, our questionnaire items did not address every single issue currently affecting IGC but did attempt to address a wide range of issues based on recent consensus guidelines and other research (1,6,7,9).”
BackgroundHalperin, I. J., Malcolm, J., Moore, S., Houlden, R. L., Cloutier, E., Gagné, S., Garon-Mailer, A., Gilmour, J. A., Houlden, R. L., Huffman, M., et al. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.04.009 · Cited by 16
Perioperative management of adult diabetic patients. Postoperative period
Cheisson, G., Jacqueminet, S., Cosson, E., Ichaï, C., Leguerrier, A.-M., Catargi, B., Ouattara, A., Tauveron, I., Valensi, P. E., & Benhamou, D. (2018) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2018.02.023 · Cited by 19
Wallia, A., Gupta, S., Garcia, C., Schmidt, K., Oakes, D. J., Aleppo, G., Glossop, V., Andrei, A., Grady, K. L., McGee, E. C., et al. (2013) · Endocrine Practice · doi:10.4158/ep13354.or · Cited by 16
A clinician's guide to the treatment of foot burns occurring in diabetic patients
Jones, L. M., Coffey, R., Khandelwal, S., Atway, S. A., Gordillo, G. M., Murphy, C. V., Fries, J. A., & Dungan, K. M. (2014) · Burns · doi:10.1016/j.burns.2014.01.026 · Cited by 36
“The prolonged use of sliding scale insulin when used as monotherapy has been found to be ineffective and is associated with higher complication frequency in surgical patients [62].”
Poljakova, I., Elšíková, E., Chlup, R., Kalabus, S., Hasala, P., & Zapletalová, J. (2013) · Biomedical Papers · doi:10.5507/bp.2013.049 · Cited by 19
Amor, A. J., Ríos, P., Graupera, I., Conget, I., Esmatjes, E., Comallonga, T., & Vidal, J. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2013.01.037 · Cited by 17
Gosmanov, A. R. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.002 · Cited by 19
“4 units/kg/day for thosepatientswhohaddiabetesduration<10yearsandweremostly treatedwithdiet and/ornon-insulin agents before admission [7,11,13].”
BackgroundOutcomes of hyperglycemia in patients with and without diabetes hospitalized for infectious diseases
Akirov, A., Diker‐Cohen, T., Masri‐Iraqi, H., Duskin‐Bitan, H., Shimon, I., & Gorshtein, A. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3027 · Cited by 16
“These findings are in line with previous reports indicating inpatient hyperglycemia is associated with poor outcomes.(24-26) On the other hand, intensive glycemic control can increase the risk of hypoglycemia and mortality.”
ResultGianchandani, R. Y., Pasquel, F. J., Rubin, D. J., Dungan, K. M., Vellanki, P., Wang, H., Anzola, I., Gomez, P., Hodish, I., Lathkar‐Pradhan, S., et al. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0036 · Cited by 16
“Several randomized controlled studies have reported successful algorithms for the management of inpatient hyperglycemia and diabetes and in reducing hospital complications in medicine and surgery patients with diabetes (5,6).”
BackgroundSelf-citationProactive Protocol-Based Management of Hyperglycemia and Diabetes in Colorectal Surgery Patients
Colibaseanu, D., Osagiede, O., McCoy, R. G., Spaulding, A., Habermann, E. B., Naessens, J. M., Perry, M. F., White, L. J., & Cima, R. R. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0379 · Cited by 17
Timing Is Everything: Results to an Observational Study of Mealtime Insulin Practices
Lampe, J. S., Penoyer, D., Hadesty, S., Bean, A., & Chamberlain, L. (2014) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000045 · Cited by 17
“The mealtime bolus of RAA is intended to be given with a complete meal and should not be given if less than 50% of the corresponding meal is not consumed.(10,11)”
Fayfman, M., Davis, G., Duggan, E. W., Urrutia, M., Chachkhiani, D., Schindler, J., Pasquel, F. J., Galindo, R. J., Vellanki, P., Reyes-Umpierrez, D., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.08.014 · Cited by 15
Self-citationIn-patient management of diabetes: Controversies and guidelines
Korytkowski, M. T. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.123554 · Cited by 16
Ambrus, D. B., & O’Connor, M. J. (2018) · Journal of Hospital Medicine · doi:10.12788/jhm.3109 · Cited by 16
Luzio, R. D., Dusi, R., Morigi, A., Nicolantonio, D. D., Mittermaier, P., Marchesini, G., & Bianchi, G. P. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01503-x · Cited by 15
Lichtenegger, K. M., Aberer, F., Tuca, A., Donsa, K., Höll, B., Schaupp, L. A., Plank, J., Beck, P., Fruhwald, F. M., Kamolz, L., et al. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820955243 · Cited by 15
Kennihan, M., Zohra, T., Devi, R., Srinivasan, C., Diaz, J., Howard, B. S., & Braithwaite, S. S. (2012) · Endocrine Practice · doi:10.4158/ep12107.ra · Cited by 17
Inpatient Management of T2DM and Hyperglycemia in Older Adults
DeCarlo, K., & Wallia, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1209-3 · Cited by 17
Diabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 17
Papak, J., & Kansagara, D. L. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.034 · Cited by 15
Marelli, G., Avanzini, F., Iacuitti, G., Planca, E., Frigerio, I., Busi, G., Carlino, L., Cortesi, L., Roncaglioni, M. C., & Riva, E. (2015) · Journal of Diabetes Research · doi:10.1155/2015/173956 · Cited by 17
“insulin in hospital and the frequencies reported vary widely, ranging from less than 10% to 50% [10, 25–30].”
BackgroundDiabetes management in spinal surgery
Lucke-Wold, B. P. (2022) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1906 · Cited by 17
Roberts, G. W., Larwood, C., & Krinsley, J. S. (2022) · Diabetic Medicine · doi:10.1111/dme.14930 · Cited by 14
Kuchay, M. S., Khatana, P., Mishra, M., Surendran, P., Kaur, P., Wasir, J. S., Gill, H. K., Singh, A., Jain, R., Kohli, C., et al. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02138-4 · Cited by 16
“Based on the results of previous basal-bolus insulin trials in hospitalized patients with T2D [2, 17, 18], it is reasonable to assume that the standard deviation of mean daily blood glucose is bounded above 45 mg/ dL (2.5 mmol/L) [18, 19].”
BackgroundResultInfluentialTale of two sites: capillary versus arterial blood glucose testing in the operating room
Akinbami, F., Segal, S., Schnipper, J. L., Stopfkuchen-Evans, M. F., Mills, J. T., & Rogers, S. O. (2012) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2011.10.013 · Cited by 14
Management of Inpatient Hyperglycemia
Schmeltz, L. R. (2011) · Laboratory Medicine · doi:10.1309/lmu72v7qwuduyqij · Cited by 16
Management of Diabetes Medications for Patients Undergoing Ambulatory Surgery
Vann, M. A. (2014) · Anesthesiology Clinics · doi:10.1016/j.anclin.2014.02.008 · Cited by 14
Teamwork and Collaboration for Prevention of Surgical Site Infections
Dellinger, E. P. (2016) · Surgical Infections · doi:10.1089/sur.2015.260 · Cited by 14
Batule, S., Ramos, A., Pérez-Montes de Oca, A., Fuentes, N., Martínez, S., Raga, J., Pena, X., Tural, C., Muñoz, P., Soldevila, B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102813 · Cited by 13
“A lack of adequate control of glycemia during hospitalization leads to a longer in-hospital stay, an increased incidence of infections and more hospital complications than patients without DM [1,3], which accounts for an increased necessity of healthcare resources in these patients [4,5].”
BackgroundSelf-citationPhillips, V. L., Byrd, A. L., Adeel, S., Peng, L., Smiley, D. D., & Umpierrez, G. E. (2017) · PharmacoEconomics - Open · doi:10.1007/s41669-017-0020-9 · Cited by 13
“Glycaemic control management programmes have been shown to reduce the occurrence of these events [10] and hospital costs in both critical care and cardiac patients [4, 11–13].”
BackgroundSelf-citationDimmen, A. C., Timko, S., Greenwood, J., McShane, F., & Ulinski, J. (2023) · JBI Evidence Synthesis · doi:10.11124/jbies-22-00300 · Cited by 13
“54,55 Given the modest MD in maximal blood glucose level observed in the included studies of this review, it seems possible that treat-ment and control groups received similar amounts of insulin.”
BackgroundMesser, N., Miller, B. T., Beffa, L., Petro, C. C., Krpata, D. M., de Figueiredo, S. M. P., Fafaj, A., Huang, L., Ellis, R. C., Maskal, S. M., et al. (2024) · Hernia · doi:10.1007/s10029-024-03161-2 · Cited by 13
“However, in contrast to numerous studies, our find - ings reveal that arbitrary cut-offs for HbA1c levels do not 24].”
Interventions to Improve Adherence to a Hypoglycemia Protocol
Destree, L., Vercellino, M., & Armstrong, N. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0042 · Cited by 13
Roos, J., Schürch, D., Frei, A., Lagger, S., Schwenkglenks, M. M., Vogt, A. P., Herzig, D., & Bally, L. (2023) · Diabetic Medicine · doi:10.1111/dme.15116 · Cited by 14
Glycemic Management in Medical and Surgical Patients in the Non-ICU Setting
Hawkins, K., Donihi, A. C., & Korytkowski, M. T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0340-1 · Cited by 17
Management of Patients with Type 1 Diabetes in the Hospital
Yogi-Morren, D., & Lansang, M. C. (2014) · Current Diabetes Reports · doi:10.1007/s11892-013-0458-9 · Cited by 13
Smiley, D. D., Umpierrez, G. E., Hermayer, K. L., Newton, C. A., Jacobs, S., Olson, D. E., Khan, A., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.05.007 · Cited by 15
“Patients treated with basal bolus were started at a total daily dose (TDD) of 0.5 U/kg divided half as insulin glargine once daily and the other half as scheduled insulin glulisine given before meals, plus correction doses of glulisine before meals when BG N 140 mg/dl.”
InfluentialSelf-citationPichardo-Lowden, A. R., Haidet, P., & Umpierrez, G. E. (2017) · Endocrine Practice · doi:10.4158/ep161634.ra · Cited by 15
“This strategy as the sole more of treatment has been proven to be a suboptimal treatment approach in comparison to basal-prandial insulin therapy, and one that can pose greater risks to patients (50,51).”
BackgroundResultSelf-citationHulst, A. H., Polderman, J. A. W., Kooij, F. O., Vittali, D., Lirk, P. B., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2018) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13274 · Cited by 14
Shacham, E. C., Kfir, H., Schwartz, N., & Ishay, A. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0300-0 · Cited by 15
Endocrine complications after solid-organ transplant in cystic fibrosis
Sidhaye, A. R., Goldswieg, B., Kaminski, B. A., Blackman, S. M., & Kelly, A. T. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.08.019 · Cited by 16
Hyperglycemia During the Immediate Period Following Liver Transplantation
Werner, K. T., Mackey, P., Castro, J. C., Carey, E. J., Chakkera, H. A., & Cook, C. B. (2016) · Future Science OA · doi:10.4155/fsoa-2015-0010 · Cited by 13
Cogle, S. V., Smith, S. E., Maish, G. O., Minard, G., Croce, M. A., & Dickerson, R. N. (2017) · Journal of Pharmacy and Nutrition Sciences · doi:10.6000/1927-5951.2017.07.03.6 · Cited by 13
Intensive Control of Diabetes in the Hospital: Why, How, and What is in the Future?
Hsia, E., & Draznin, B. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500637 · Cited by 13
Yamamoto, T., Yoshitomi, M., Oshimo, Y., Nishikawa, Y., Hisano, K., Nakano, K., Kawai, T., Okuchi, Y., Iguchi, K., Tanaka, E. I., et al. (2023) · Frontiers in Surgery · doi:10.3389/fsurg.2023.1150460 · Cited by 13
de Souza, A. B. C., Toyoshima, M. T. K., Cukier, P., Lottenberg, S. A., Bolta, P. M. P., Lima, E. G., Junior, C. V. S., & Nery, M. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241268352 · Cited by 12
“21,30 This strategic balance not only resulted in a lower average glycemia but also exhibited a reduction in the glucose variation coefficient, few instances of significant hyperglycemia, and decreased prevalence of hypoglycemia.”
Khan, S. A., Shields, S. A., Abusamaan, M. S., & Mathioudakis, N. N. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108305 · Cited by 14
Glycemic Variability and Glycemic Control in the Acutely Ill Cardiac Patient
Moore, J., & Dungan, K. M. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.006 · Cited by 14
Helmle, K. E., Edwards, A. L., Kushniruk, A. W., & Borycki, E. M. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.059 · Cited by 12
The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
(AME), A. O. B. O. A. M. E., Castellano, E., Attanasio, R., Giagulli, V. A., Boriano, A., Terzolo, M., Papini, E., Guastamacchia, E., Monti, S., Aglialoro, A., et al. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0358-2 · Cited by 12
Challenges and Strategies for Inpatient Diabetes Management in Older Adults
Gosmanov, A. R., Mendez, C. E., & Umpierrez, G. E. (2020) · Diabetes Spectrum · doi:10.2337/ds20-0008 · Cited by 12
“In general surgery patients in the RABBIT 2 Surgery (Randomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery) trial (7), a basal-bolus regimen resulted in significant improvement in glucose control and a significant reduction in the freque…”
Self-citationBuggy, D. J., Nolan, R., Coburn, M., Columb, M. O., Hermanides, J., Hollman, M. W., & Zarbock, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044394 · Cited by 13
Implementing a pharmacist consultation model for multimodal insulin therapy
Hodges, A., Hall, J. B., Castellanos, E., Laue, E., Ellis, T., & Oelschlaeger, L. M. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150941 · Cited by 12
Lee, D., Lee, R. Y., Gowda, N. B., Probasco, W. V., Stake, S. N., Ibrahim, G., & Pandarinath, R. (2019) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2019.07.009 · Cited by 13
Hyperglycemia in-hospital management
Prieto, L. M. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810397083 · Cited by 13
Cheong, C. M., Golder, A. M., Horgan, P. G., Roxburgh, C. S. D., & McMillan, D. C. (2022) · Oncology Letters · doi:10.3892/ol.2022.13416 · Cited by 13
“844 42‐48 3/0 (‐) 14/3 (21) 18/5 (28) 14/4 (29) 49/12 (25) 0.”
BackgroundInfluential
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.